- recruitingHuman Pharmacology (Phase I)- Other
A clinical trial of MK-6916 in healthy participants (MK-6916-010)
This early-stage Phase 1 trial tests a new medicine called MK-6916. Researchers want to see how safe it is and how the body handles it in healthy volunteers. While MK-6916 is being developed to treat acute and chronic pain, participants in this study must be in good general health.
Belgium - recruitingHuman Pharmacology (Phase I)- Other
A clinical study of MK-6916 and placebo in healthy people (MK-6916-003)
This study is looking at a new medicine called MK-6916 in healthy men, to understand how it works and if it's safe. It's an early-stage study to help us learn more about potential treatments for pain.
Belgium - recruitingHuman Pharmacology (Phase I)- Other
A clinical study of MK-6916 in healthy people (MK-6916-002)
This study is looking for healthy adults to test a new medicine, MK-6916. It's a very early study to see how the medicine works in the body and if it's safe, with the long-term goal of helping people with pain.
Belgium - recruitingHuman Pharmacology (Phase I)- Other
A clinical study of MK-6916 in healthy people (MK-6916-006)
This study is looking at a new medicine called MK-6916 in healthy people. It's an early stage trial to learn how the medicine works in the body and if it's safe, as it might help people with pain in the future.
Belgium - recruitingHuman Pharmacology (Phase I)- First administration to humans
A Single-Ascending-Dose Study of MK6916 in Healthy Participants
This study is testing a new medicine, MK6916, for pain in healthy volunteers. It's the first time this medicine is being given to people, starting with very small doses to check it's safe and how the body handles it.
Belgium - recruitingHuman Pharmacology (Phase I)- First administration to humans
A Single-Ascending-Dose Study of MK-4318 in Healthy Participants
This study is looking into a new medicine called MK-4318 for pain. It's the first time this medicine is being given to people. Researchers want to see if it's safe and how the body handles different doses in healthy volunteers. It could help us find new ways to treat pain in the future.
Belgium